Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer.
作者： Abdulaziz Mohamed Aleisa , Abdulaziz Abdulrhman Al-Yahya , Salim Salih Al-Rejaie , Mohammad Hamad Al-Akeely , Abdulmalik Alsheikh
DOI: 10.1700/1361.15109
关键词:
摘要: Aims and backgroundTriple-negative breast cancer (TNBC) is an aggressive subtype of that lacks the expression hormone receptors human epidermal growth factor receptor 2 (HER2)....
sagepub.com
sci-hub.st 参考文章(67)
Romeo Bascioni, Angelo Martignetti, Sergio Crispino, Camilla Casi, Amalia Falzetta, Sandra Biancanelli, Francesca Rastelli, Lucio Giustini, Triple-negative Breast Cancer: Current State of the Art Tumori. ,vol. 96, pp. 875- 888 ,(2010) , 10.1700/548.6505
Mitchell Goldfarb, The fibroblast growth factor family. Cell Growth & Differentiation. ,vol. 1, pp. 439- ,(1990)
William R. Greco, Hans Minderman, Kieran L. O’loughlin, Maria R. Baer, Attaphol Pawarode, Rapamycin overcomes multidrug resistance (MDR) mediated by P-glycoprotein (Pgp), Multidrug Resistance Protein-1 (MRP-1), Breast Cancer Resistance Protein (BCRP) and Lung Resistance Protein (LRP) and synergizes with substrate drugs in MDR cells. Cancer Research. ,vol. 66, pp. 1270- 1270 ,(2006)
R. A. Dent, G. J. Lindeman, M. Clemons, H. Wildiers, A. Chan, N. J. McCarthy, C. F. Singer, E. S. Lowe, K. Kemsley, J. Carmichael, Safety and efficacy of the oral PARP inhibitor olaparib (AZD2281) in combination with paclitaxel for the first- or second-line treatment of patients with metastatic triple-negative breast cancer: Results from the safety cohort of a phase I/II multicenter trial. Journal of Clinical Oncology. ,vol. 28, pp. 1018- 1018 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.1018
E FILARDO, J QUINN, E SABO, Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids. ,vol. 73, pp. 870- 873 ,(2008) , 10.1016/J.STEROIDS.2007.12.025
Hannah Farmer, Nuala McCabe, Christopher J. Lord, Andrew N. J. Tutt, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa, Krystyna J. Dillon, Ian Hickson, Charlotte Knights, Niall M. B. Martin, Stephen P. Jackson, Graeme C. M. Smith, Alan Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature. ,vol. 434, pp. 917- 921 ,(2005) , 10.1038/NATURE03445
Napoleone Ferrara, None, The role of vascular endothelial growth factor in pathological angiogenesis Breast Cancer Research and Treatment. ,vol. 36, pp. 127- 137 ,(1995) , 10.1007/BF00666035
Remacle A, Birembaut P, Stetler-Stevenson Wg, Nawrocki B, Nöel A, Gilbert N, Polette M, Foidart M, Stas I, Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy Virchows Archiv. ,vol. 424, pp. 641- 645 ,(1994) , 10.1007/BF01069745
S M. Rodriguez-Pinilla, R. L Jones, M. B K Lambros, E. Arriola, K. Savage, M. James, S. E Pinder, J. S Reis-Filho, MYC amplification in breast cancer: a chromogenic in situ hybridisation study Journal of Clinical Pathology. ,vol. 60, pp. 1017- 1023 ,(2006) , 10.1136/JCP.2006.043869
Carey K. Anders, Chaitanya R. Acharya, David S. Hsu, Gloria Broadwater, Katherine Garman, John A. Foekens, Yi Zhang, Yixin Wang, Kelly Marcom, Jeffrey R. Marks, Sayan Mukherjee, Joseph R. Nevins, Kimberly L. Blackwell, Anil Potti, Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors PLoS ONE. ,vol. 3, pp. e1373- ,(2008) , 10.1371/JOURNAL.PONE.0001373